vs
Side-by-side financial comparison of MAXLINEAR, INC (MXL) and NATURES SUNSHINE PRODUCTS INC (NATR). Click either name above to swap in a different company.
MAXLINEAR, INC is the larger business by last-quarter revenue ($137.2M vs $123.8M, roughly 1.1× NATURES SUNSHINE PRODUCTS INC). NATURES SUNSHINE PRODUCTS INC runs the higher net margin — 3.3% vs -32.9%, a 36.2% gap on every dollar of revenue. On growth, MAXLINEAR, INC posted the faster year-over-year revenue change (43.0% vs 4.7%). Over the past eight quarters, MAXLINEAR, INC's revenue compounded faster (22.1% CAGR vs 5.6%).
MaxLinear, Inc. is an American electronic hardware company. Founded in 2003, it provides highly integrated radio-frequency (RF) analog and mixed-signal semiconductor products for broadband communications applications. It is a New York Stock Exchange-traded company.
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
MXL vs NATR — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $137.2M | $123.8M |
| Net Profit | $-45.1M | $4.1M |
| Gross Margin | 57.5% | 72.5% |
| Operating Margin | 30.0% | 4.3% |
| Net Margin | -32.9% | 3.3% |
| Revenue YoY | 43.0% | 4.7% |
| Net Profit YoY | -203.0% | 1379.4% |
| EPS (diluted) | $-0.52 | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $137.2M | — | ||
| Q4 25 | $136.4M | $123.8M | ||
| Q3 25 | $126.5M | $128.3M | ||
| Q2 25 | $108.8M | $114.8M | ||
| Q1 25 | $95.9M | $113.2M | ||
| Q4 24 | $92.2M | $118.2M | ||
| Q3 24 | $81.1M | $114.6M | ||
| Q2 24 | $92.0M | $110.6M |
| Q1 26 | $-45.1M | — | ||
| Q4 25 | $-14.9M | $4.1M | ||
| Q3 25 | $-45.5M | $5.3M | ||
| Q2 25 | $-26.6M | $5.3M | ||
| Q1 25 | $-49.7M | $4.7M | ||
| Q4 24 | $-57.8M | $-321.0K | ||
| Q3 24 | $-75.8M | $4.3M | ||
| Q2 24 | $-39.3M | $1.3M |
| Q1 26 | 57.5% | — | ||
| Q4 25 | 57.6% | 72.5% | ||
| Q3 25 | 56.9% | 73.3% | ||
| Q2 25 | 56.5% | 71.7% | ||
| Q1 25 | 56.1% | 72.1% | ||
| Q4 24 | 55.6% | 72.0% | ||
| Q3 24 | 54.4% | 71.3% | ||
| Q2 24 | 54.6% | 71.4% |
| Q1 26 | 30.0% | — | ||
| Q4 25 | -10.9% | 4.3% | ||
| Q3 25 | -32.7% | 7.0% | ||
| Q2 25 | -22.6% | 3.7% | ||
| Q1 25 | -48.0% | 5.4% | ||
| Q4 24 | -44.7% | 3.8% | ||
| Q3 24 | -82.3% | 4.6% | ||
| Q2 24 | -44.4% | 5.1% |
| Q1 26 | -32.9% | — | ||
| Q4 25 | -10.9% | 3.3% | ||
| Q3 25 | -36.0% | 4.2% | ||
| Q2 25 | -24.4% | 4.6% | ||
| Q1 25 | -51.8% | 4.2% | ||
| Q4 24 | -62.8% | -0.3% | ||
| Q3 24 | -93.4% | 3.8% | ||
| Q2 24 | -42.7% | 1.2% |
| Q1 26 | $-0.52 | — | ||
| Q4 25 | $-0.17 | $0.23 | ||
| Q3 25 | $-0.52 | $0.30 | ||
| Q2 25 | $-0.31 | $0.28 | ||
| Q1 25 | $-0.58 | $0.25 | ||
| Q4 24 | $-0.68 | $-0.02 | ||
| Q3 24 | $-0.90 | $0.23 | ||
| Q2 24 | $-0.47 | $0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $61.1M | $93.9M |
| Total DebtLower is stronger | $123.8M | — |
| Stockholders' EquityBook value | $454.2M | $161.6M |
| Total Assets | $771.3M | $261.1M |
| Debt / EquityLower = less leverage | 0.27× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.1M | — | ||
| Q4 25 | $72.8M | $93.9M | ||
| Q3 25 | $111.9M | $95.6M | ||
| Q2 25 | $108.6M | $81.3M | ||
| Q1 25 | $102.8M | $86.5M | ||
| Q4 24 | $118.6M | $84.7M | ||
| Q3 24 | $148.5M | $78.7M | ||
| Q2 24 | $185.1M | $68.7M |
| Q1 26 | $123.8M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $454.2M | — | ||
| Q4 25 | $451.9M | $161.6M | ||
| Q3 25 | $464.7M | $166.7M | ||
| Q2 25 | $488.3M | $163.7M | ||
| Q1 25 | $493.2M | $167.1M | ||
| Q4 24 | $516.3M | $161.0M | ||
| Q3 24 | $556.9M | $162.6M | ||
| Q2 24 | $617.3M | $156.4M |
| Q1 26 | $771.3M | — | ||
| Q4 25 | $796.4M | $261.1M | ||
| Q3 25 | $808.1M | $264.8M | ||
| Q2 25 | $863.7M | $254.9M | ||
| Q1 25 | $855.3M | $252.7M | ||
| Q4 24 | $864.6M | $240.9M | ||
| Q3 24 | $895.3M | $245.3M | ||
| Q2 24 | $973.2M | $235.8M |
| Q1 26 | 0.27× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $9.9M |
| Free Cash FlowOCF − Capex | — | $7.6M |
| FCF MarginFCF / Revenue | — | 6.1% |
| Capex IntensityCapex / Revenue | — | 1.9% |
| Cash ConversionOCF / Net Profit | — | 2.41× |
| TTM Free Cash FlowTrailing 4 quarters | — | $28.8M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $10.4M | $9.9M | ||
| Q3 25 | $10.1M | $18.5M | ||
| Q2 25 | $10.5M | $4.3M | ||
| Q1 25 | $-11.4M | $2.6M | ||
| Q4 24 | $-27.8M | $12.2M | ||
| Q3 24 | $-30.7M | $9.6M | ||
| Q2 24 | $-2.7M | $1.3M |
| Q1 26 | — | — | ||
| Q4 25 | $6.7M | $7.6M | ||
| Q3 25 | $4.4M | $16.8M | ||
| Q2 25 | $9.3M | $3.0M | ||
| Q1 25 | $-13.4M | $1.5M | ||
| Q4 24 | $-30.0M | $10.0M | ||
| Q3 24 | $-34.9M | $7.9M | ||
| Q2 24 | $-5.7M | $-2.0M |
| Q1 26 | — | — | ||
| Q4 25 | 4.9% | 6.1% | ||
| Q3 25 | 3.5% | 13.1% | ||
| Q2 25 | 8.6% | 2.6% | ||
| Q1 25 | -14.0% | 1.3% | ||
| Q4 24 | -32.6% | 8.5% | ||
| Q3 24 | -43.0% | 6.9% | ||
| Q2 24 | -6.2% | -1.9% |
| Q1 26 | — | — | ||
| Q4 25 | 2.7% | 1.9% | ||
| Q3 25 | 4.5% | 1.3% | ||
| Q2 25 | 1.1% | 1.2% | ||
| Q1 25 | 2.1% | 1.0% | ||
| Q4 24 | 2.4% | 1.9% | ||
| Q3 24 | 5.1% | 1.5% | ||
| Q2 24 | 3.3% | 3.0% |
| Q1 26 | — | — | ||
| Q4 25 | — | 2.41× | ||
| Q3 25 | — | 3.46× | ||
| Q2 25 | — | 0.81× | ||
| Q1 25 | — | 0.55× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.21× | ||
| Q2 24 | — | 0.97× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MXL
Segment breakdown not available.
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
